期刊文献+

乳腺癌新指标的筛选及其临床价值验证 被引量:1

原文传递
导出
摘要 CA15—3是目前应用最多的乳腺癌指标,但只有不足10%的早期乳腺癌和30%-75%的晚期乳腺癌患者中出现阳性结果。相对血清抗原检测,血清抗体检测的灵敏度更高,理论和研究也证实抗体较抗原具更大的早期诊断价值。我们利用噬菌体展示技术从全基因组表达文库中筛选乳腺癌新指标,比较乳腺癌病灶组织和血清中新指标表达的相关性,验证其在乳腺癌诊断和预后中的临床应用价值。
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第11期2005-2006,共2页 Chinese Journal of Experimental Surgery
基金 绍兴市科技计划资助项目(2009A23005) 浙江省医药卫生科学研究基金(2009A208) 浙江省科技厅公益类项目(2010C33010)
  • 相关文献

参考文献5

  • 1Catto JW,Abbod MF,Wild PJ,et al.The application of artificial intelligence to microarray data:identification of a novel gene signature to identify bladder cancer progression.Eur Urol,2010,57:398-406.
  • 2Barraclough DL,Sewart S,Rudland PS,et al.Microarray analysis of suppression subtracted hybridisation libraries identifies genes associated with breast cancer progression.Cell Oncol,2010,32:87-99.
  • 3Zhong L,Hidalgo GE,Stromberg A J,et al.Using protein microarray as a diagnostic assay for non-small cell lung cancer.Am J Respir Crit Care Med,2005,172:1308-1314.
  • 4Balasubramani M,Day BW,Schoen RE,et al.Altered expression and localization of creatine kinase B,heterogeneous nuclear ribonucleoprotein F,and high mobility group box 1 proteir in the nuclear matrix associated with colon cancer.Cancer Res,2006,66:763-769.
  • 5Baik M,Hennighausen L,Choi y.In situ localization of WDNM1 and ferritin heavy chain gene expression in mammary gland.Mol Cells,1997,7:448-450.

同被引文献10

  • 1Birkenkamp - Demtroder K, Olesen SH, Srensen FB, et al. Differen- tial gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid[J]. Gut, 2005, 54:374 - 384.
  • 2Nakashima K, Shimada H, Ochiai T, et al. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of pa- tients with esophageal squamous cell carcinoma [ J]. Int J Cancer, 2004, 112(6) :1029 - 1035.
  • 3Santin AD, Zhan F, Bellone S, et al. Gene expression profiles in pri- mary ovarian serous papillary tumors and normal ovarian epithelium:i- dentification of candidate molecular markers for ovarian cancer diagno- sis and therapy[ J]. Int J Cancer, 2004, 112 (1) :14 -25.
  • 4Iacobuzio - Donahue CA, Maitra A, Shen - Ong GL, et al. Discovery of novel tumor markers of pancreatic cancer using global gene expres- sion technology[J]. Am J Pathol, 2002, 160(4) :1239 - 1249.
  • 5Coldren CD, FIelfrleh BA, Witta SE, et al. Baseline gene expression predicts sensitivity to gefitinib in nonsmall cell lung cancer cell lines [J]. Mol CaneerRes, 2006, 4(8) :521- 528.
  • 6Mtihlmann G, Spizzo G, Gostner J, et al. TROP2 expression as prognos- tic marker for gastric carcinoma[ J ]. Clin Pathol,2009,62 : 152 - 158.
  • 7Wang J, Day R, Dong Y, et al. Identification of Trop - 2 as an onco- gene and an attractive therapeutic target in colon cancers [ J ]. Mol Cancer Ther, 2008, 7 (2) :280 - 285.
  • 8Pau NIB, Zakaria Z, Muhammad R, et al. Gene expression patterns distinguish breast carcinomas from normal breast tissues:the malaysian context[ J ]. Pathol Res Pract,2010,206 (4) :223 - 228.
  • 9Tan EM, Zhang J. Autoantibodies to tumor associated antigens:reporters from the immune system [ J ]. Immunol Rev,2008,222 ( 1 ) :328 - 340.
  • 10Admon A, Shoshan SH. Antibodies as oncogenes:a hypothesis [ J ]. Med Hypotheses, 2006, 67 ( 3 ) :471 - 473.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部